Figure 1: Waterfall plot showing percent change from baseline in total polyp burden at Week 13 (end of treatment) for efficacy-evaluable patients receiving REC-4881 (4 mg QD).
Figure 1: Waterfall plot showing percent change from baseline in total polyp burden at Week 13 (end of treatment) for efficacy-evaluable patients receiving REC-4881 (4 mg QD).